Clinical trials
Enrolling by invitation trials in Austria
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
45 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2018 | 1 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 5 |
| 2024 | 11 |
| 2025 | 5 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Enrolling by invitation | 45 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Medical University of Graz | 5 |
| Medical University of Vienna | 2 |
| Novo Nordisk A/S | 2 |
| Pharvaris Netherlands B.V. | 2 |
| AOP Orphan Pharmaceuticals AG | 1 |
| Alexion Pharmaceuticals, Inc. | 1 |
| Alnylam Pharmaceuticals | 1 |
| Ascendis Pharma Growth Disorders A/S | 1 |
| Biohaven Therapeutics Ltd. | 1 |
| Christian Dorfer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Epilepsy | 3 |
| Amyloidosis | 2 |
| Angioedemas, Hereditary | 2 |
| Cardiomyopathies | 2 |
| Cardiovascular Diseases | 2 |
| Dermatomyositis | 2 |
| Drug Resistant Epilepsy | 2 |
| Epilepsies, Partial | 2 |
| Heart Failure | 2 |
| Hypertension, Pulmonary | 2 |
Trials
Showing 26 to 45 of 45. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.